A computational assessment of the independent contribution of changes in canine trabecular bone volume fraction and microarchitecture to increased bone strength with suppression of bone turnover

Journal of Biomechanics

Volumn 40, Issue 15, 2007, Pages 3424-3431

  Eswaran, Senthil K ^a   Allen, Matthew R ^b   Burr, David B ^b   Keaveny, Tony M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of California at Berkeley   (United States)

Author keywords

Antiresorptive treatment; Bone quality; Bone strength; Microarchitecture; Stress risers; Suppressed bone turnover; Trabecular bone

Indexed keywords

BONE; COMPACTION; FINITE ELEMENT METHOD; MATHEMATICAL MODELS; VOLUME FRACTION;

ANTIRESORPTIVE TREATMENT; BONE QUALITY; STRESS RISERS; SUPPRESSED BONE TURNOVER; TRABECULAR BONE;

BIOMECHANICS;

BISPHOSPHONIC ACID DERIVATIVE; RISEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE REMODELING; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; DOG; DRUG MEGADOSE; FEMALE; FEMUR NECK; FINITE ELEMENT ANALYSIS; HUMAN; HUMAN TISSUE; LOADING TEST; MICRO-COMPUTED TOMOGRAPHY; MONKEY; NONHUMAN; PRIORITY JOURNAL; SHEEP; SPECIES DIFFERENCE; THREE DIMENSIONAL IMAGING; TRABECULAR BONE; TREATMENT OUTCOME; VERTEBRA BODY; YOUNG MODULUS;

ANIMALS; BONE AND BONES; BONE DENSITY; COMPUTER SIMULATION; DOGS; FEMALE; FINITE ELEMENT ANALYSIS; HUMANS; MODELS, ANIMAL; STRESS, MECHANICAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35449003698     PISSN: 00219290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiomech.2007.05.013     Document Type: Article

References (34)

1. Adams, M.F., Bayraktar, H.H., Keaveny, T.M., Papadopoulos, P., 2004. Ultrascalable implicit finite element analyses in solid mechanics with over a half a billion degrees of freedom. In: ACM/IEEE Proceedings of SC2004: High Performance Networking and Computing.
2. Allen M.R., Hock J.M., and Burr D.B. Periosteum: biology, regulation, and response to osteoporosis therapies. Bone 35 (2004) 1003-1012
3. Allen M.R., Iwata K., Phipps R., and Burr D.B. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 39 (2006) 872-879
4. Allen M.R., Iwata K., Sato M., and Burr D.B. Raloxifene enhances vertebral mechanical properties independent of bone density. Bone 39 (2006) 1130-1135
5. Bevill G., Eswaran S.K., Gupta A., Papadopoulos P., and Keaveny T.M. Influence of bone volume fraction and architecture on computed large-deformation failure mechanisms in human trabecular bone. Bone 39 (2006) 1218-1225
6. Boivin G.Y., Chavassieux P.M., Santora A.C., Yates J., and Meunier P.J. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27 (2000) 687-694
7. Borah B., Dufresne T.E., Chmielewski P.A., Johnson T.D., Chines A., and Manhart M.D. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. Bone 34 (2004) 736-746
8. Borah B., Ritman E.L., Dufresne T.E., Jorgensen S.M., Liu S., Sacha J., Phipps R.J., and Turner R.T. The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. Bone 37 (2005) 1-9
9. Burr D.B., Miller L., Grynpas M., Li J., Boyde A., Mashiba T., Hirano T., and Johnston C.C. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone 33 (2003) 960-969
10. Cummings S.R., Karpf D.B., Harris F., Genant H.K., Ensrud K., LaCroix A.Z., and Black D.M. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. American Journal of Medicine 112 (2002) 281-289
11. Day J.S., Ding M., Bednarz P., van der Linden J.C., Mashiba T., Hirano T., Johnston C.C., Burr D.B., Hvid I., Sumner D.R., and Weinans H. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. Journal of Orthopaedic Research 22 (2004) 465-471
12. Delmas P.D. How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?. Bone 27 (2000) 1-3
13. Ding M., Day J.S., Burr D.B., Mashiba T., Hirano T., Weinans H., Sumner D.R., and Hvid I. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. Calcified Tissue International 72 (2003) 737-744
14. Fenech C.M., and Keaveny T.M. A cellular solid criterion for predicting the axial-shear failure properties of trabecular bone. Journal of Biomechanical Engineering 121 (1999) 414-422
15. Ford C.M., and Keaveny T.M. The dependence of shear failure properties of bovine tibial trabecular bone on apparent density and trabecular orientation. Journal of Biomechanics 29 (1996) 1309-1317
16. Gibson L.J. The mechanical behavior of cancellous bone. Journal of Biomechanics 18 (1985) 317-328
17. Guo X.E., and Kim C.H. Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone 30 (2002) 404-411
18. Harrigan T.P., Jasty M., Mann R.W., and Harris W.H. Limitations of the continuum assumption in cancellous bone. Journal of Biomechanics 21 (1988) 269-275
19. Hernandez C.J., Gupta A., and Keaveny T.M. A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. Journal of Bone and Mineral Research 21 (2006) 1248-1255
20. Hernandez C.J., and Keaveny T.M. A biomechanical perspective on bone quality. Bone 39 (2006) 1173-1181
21. Hildebrand T., Laib A., Müller R., Dequeker J., and Rüegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. Journal of Bone and Mineral Research 14 (1999) 1167-1174
22. Ito M., Nishida A., Aoyagi K., Uetani M., Hayashi K., and Kawase M. Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia. Osteoporosis International 16 (2005) 1042-1048
23. Lill C.A., Gerlach U.V., Eckhardt C., Goldhahn J., and Schneider E. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporosis International 13 (2002) 407-414
24. Mashiba T., Turner C.H., Hirano T., Forwood M.R., Johnston C.C., and Burr D.B. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28 (2001) 524-531
25. Muller R., Hannan M., Smith S.Y., and Bauss F. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey. Journal of Bone and Mineral Research 19 (2004) 1787-1796
26. Nádai A. Torsion of a Round Bar. The Stress-Strain Curve in Shear. Theory of Flow of Solids (1950), McGraw-Hill, New York
27. Niebur G.L., Feldstein M.J., and Keaveny T.M. Biaxial failure behavior of bovine tibial trabecular bone. Journal of Biomechanical Engineering 124 (2002) 699-705
28. Parfitt A.M. High bone turnover is intrinsically harmful: two paths to a similar conclusion. The Parfitt view. Journal of Bone and Mineral Research 17 (2002) 1558-1559 author reply 1560
29. Riggs B.L., and Melton III L.J. Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. Journal of Bone and Mineral Research 17 (2002) 11-14
30. Roschger P., Rinnerthaler S., Yates J., Rodan G.A., Fratzl P., and Klaushofer K. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29 (2001) 185-191
31. Shen V., Dempster D.W., Birchman R., Mellish R.W., Church E., Kohn D., and Lindsay R. Lack of changes in histomorphometric, bone mass, and biochemical parameters in ovariohysterectomized dogs. Bone 13 (1992) 311-316
32. Stolken J.S., and Kinney J.H. On the importance of geometric nonlinearity in finite-element simulations of trabecular bone failure. Bone 33 (2003) 494-504
33. Storm T., Steiniche T., Thamsborg G., and Melsen F. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. Journal of Bone and Mineral Research 8 (1993) 199-208
34. Ulrich D., van Rietbergen B., Laib A., and Ruegsegger P. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25 (1999) 55-60